Monday, 26 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
CompanyDeals

Fortune Care Raises Over RMB 100 Million in Series C+ Financing Round

January 26, 2025
CompanyDeals

Guangzhou Mygene Raises ‘Hundreds of Millions’ in Series C Financing Led by Efund Capital

January 26, 2025
Company

WuXi Biologics Receives First GMP Certificate from Ireland HPRA

January 26, 2025
R&D

CARsgen Develops New CAR-T Technique to Enhance Anti-Tumor Activity

January 26, 2025
CompanyDrug

SciClone Pharmaceuticals’ Vaborem IND Filing Accepted by NMPA

January 26, 2025
CompanyDrug

Luye Pharma’s Paliperidone Palmitate Accepted for NMPA Review

January 26, 2025
Policy / Regulatory

China Downgrades COVID-19 from Class A to Class B Infectious Disease

January 26, 2025
CompanyDeals

Carrier Biomed Raises ‘Tens of Millions’ in Series A+ Financing Round

January 26, 2025
Company

Everest Medicines Launches First Phase of Global mRNA Vaccine Manufacturing Site

January 26, 2025
CompanyDrug

InnoCare Pharma Receives Hong Kong Approval for Tafasitamab in DLBCL

January 26, 2025
CompanyDeals

LeadArt Biotechnologies Raises USD 6 Million in Pre-Series A Round

January 26, 2025
CompanyDrug

Simcere Receives NMPA Clearance for SIM0237 Clinical Study

January 26, 2025
1 2 3 4 5 … 22 23
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up